UPDATE: Regenxbio (RGNX) Reports Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for Treatment of Wet AMD
Tweet Send to a Friend
(Updated - May 7, 2019 5:07 PM EDT)
REGENXBIO Inc. (NASDAQ: RGNX) today an update to its Phase I/IIa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
REGENXBIO Inc. (NASDAQ: RGNX) today an update to its Phase I/IIa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
